HETERO USA INC

Company Introduction: HETERO USA INC

Business Type: Trading Company / Distributor

HETERO USA INC is the U.S. subsidiary of Hetero Drugs, a prominent Indian pharmaceutical company. Its main function is to market, sell, and distribute a diverse portfolio of pharmaceutical products within the United States. These products include active pharmaceutical ingredients (APIs) and finished dosage forms, covering various therapeutic segments such as antivirals, oncology, cardiovascular, and central nervous system disorders.

It is important to note that HETERO USA INC is primarily based in the United States and acts as the commercial arm for its parent company's products in the U.S. market. While Hetero's global network may involve operations or partnerships in various regions, including potentially Taiwan, HETERO USA INC itself is not a manufacturing factory located in Taiwan. Its role is predominantly that of a trading company or distributor, managing the commercialization and supply chain of pharmaceutical products rather than manufacturing them.

Hetero USA Inc. is a subsidiary of the Indian pharmaceutical company Hetero Labs Limited. The company primarily focuses on the distribution and marketing of generic pharmaceutical products and active pharmaceutical ingredients (APIs) in the United States. Its product portfolio includes:

Antiretrovirals: A wide range of medications for the treatment of HIV/AIDS.

Hepatitis Treatments: Therapies for Hepatitis C and other viral infections.

Oncology Products: Generic medications used in the treatment of various types of cancer.

Cardiovascular Drugs: Medications designed to manage heart-related conditions.

Neurology Medications: Drugs targeting central nervous system disorders.

Active Pharmaceutical Ingredients (APIs): Bulk drug substances supplied to other pharmaceutical manufacturers for the production of finished dosage forms.

Specialty Generics: Various other complex generic formulations across multiple therapeutic categories.